Dietary FAs have been implicated in the etiology of coronary heart disease (CHD) (1). Results from cohort studies suggest that long-chain n-3 PUFAs are associated with a lower CHD risk and trans-fats are associated with a higher CHD risk (2, 3). Higher consumption of n-6 PUFAs has also been associated with a lower cardiovascular risk (4, 5), but concerns remain about their pro-inflammatory and pro-thrombotic potential through synthesis of oxidized metabolites (6, 7).Oxylipins are a group of oxidized metabolites of PUFAs metabolized through various enzymatic pathways. These include the more conventional subclass of 20-carbon oxylipins derived from arachidonic acid [AA, 20:4(n-6)], named eicosanoids, and other more recently identified oxylipins that are metabolized via lipoxygenase and cytochrome P450 pathways. These oxylipins have hormonelike effects on inflammation, vasoconstriction, and blood clotting in experimental studies (8) Circulating long-chain n-3 FAs and stearic acid were associated with a lower and AA was associated with a higher AMI risk in this Chinese population. The association between the oxylipin TXB 2 and AMI requires further research.-Sun, Y.,